Skip to main content

Skin and blood cancers

Cutaneous T-cell lymphoma: symptoms, treatment and outlook

Cutaneous T-cell lymphoma (CTCL) is a rare cancer of white blood cells that starts in the skin. The commonest type, mycosis fungoides, usually begins as dry, itchy patches that look like eczema or psoriasis and develops slowly over years. Most people are diagnosed early and have a normal life span. It is treated to control symptoms, usually with skin-directed therapy, rather than cured.

Last checked: 2026-10-18

Key facts

At a glance.

  • What it is

    Lymphoma Action describes T-cell skin lymphomas as non-Hodgkin lymphomas that start in the skin from T cells, a type of white blood cell in the immune system.

  • How rare

    Lymphoma Action says fewer than 400 people are diagnosed with T-cell skin lymphoma in the UK each year. The British Association of Dermatologists (BAD) says about 450 people a year are diagnosed with mycosis fungoides.

  • First signs

    Most begin as patches of dry, discoloured (usually red) skin, often on the buttocks or torso, which can be itchy and can look like dermatitis, eczema or psoriasis.

  • Usually slow and early

    Lymphoma Action says mycosis fungoides develops over many years, is rarely life-threatening, and about 3 out of 4 people have early-stage disease when first diagnosed.

  • Not contagious

    BAD says you cannot catch or pass on mycosis fungoides, and it is not an infection even though the name suggests a fungal one.

  • Treatment

    BAD says most patients only ever need skin-directed therapy such as steroid creams, chlormethine gel or light therapy. There is no known cure, and the condition usually comes back after treatment.

  • Outlook

    BAD says most people with mycosis fungoides have a normal life span, although people with more advanced stages may have worse outcomes.

Cutaneous T-cell lymphoma symptoms

Lymphoma Action says most T-cell skin lymphomas begin as patches of dry, discoloured skin, usually red, commonly on the buttocks or between the waist and shoulders, but they can develop elsewhere. They develop slowly, often over years, and may be itchy or sometimes painful. BAD says the most common symptom of mycosis fungoides is long-term, generalised itching.

Both sources stress that early patches can look like common skin conditions such as eczema, dermatitis or psoriasis. This is why diagnosis can take a long time. Lymphoma Action reminds readers that T-cell skin lymphomas are rare and many conditions look similar, so these skin changes are much more likely to be something else.

  • Patch stage: irregular, oval or ring-shaped, dry or scaly flat patches, often on skin not usually exposed to the sun.

  • Plaque stage: patches that thicken into raised areas, which can be itchy and sometimes break down (ulcerate).

  • Tumour stage: larger raised lumps that can ulcerate, weep and be painful; only a small proportion of people develop them.

  • Erythroderma: skin that becomes red, thickened and sore all over, which is uncommon.

  • Other possible features: lighter or darker patches, thickened or cracked skin on the palms or soles, hair loss in affected areas, and swollen lymph glands in the neck, armpits or groin.

  • A small number of people have weight loss, fevers or night sweats, and Lymphoma Action advises seeing a GP if you are concerned about these.

How is cutaneous T-cell lymphoma treated?

BAD says the aim of treatment is to control symptoms and improve quality of life, and that no treatments have been shown to improve survival, although with early diagnosis and treatment people often live for many years without symptoms. Periods with no treatment are common. Lymphoma Action says mycosis fungoides can be very well controlled with treatment but tends to come back when treatment is stopped, and a few people do not need treatment at first.

The first step is good skin care with regular moisturisers (emollients). Most people only ever need skin-directed therapy, which treats the skin alone. If that does not control the condition, the case is discussed by a specialist skin lymphoma multidisciplinary team and other treatments may be offered; BAD says most patients do not need these.

Sézary syndrome affects the blood as well as the skin and needs whole-body treatment. Lymphoma Action says the first choice is usually extracorporeal photopheresis (ECP), which may be combined with methotrexate, bexarotene or interferon-alfa.

Treatments for mycosis fungoides and Sézary syndrome (BAD; Lymphoma Action)
LevelTreatmentsNotes
Skin careRegular emollientsMay be all that is needed for stage 1 disease (Lymphoma Action)
Skin-directed therapySteroid creams or ointments, chlormethine gel, phototherapy, radiotherapy to specific areasMost patients will only ever need these (BAD)
Whole-skin radiotherapyTotal skin electron beam therapyFor more widespread disease (BAD)
Systemic treatmentMethotrexate tablets, interferon alpha, bexarotene tablets, chemotherapy, antibody therapy (mogamulizumab, brentuximab), photopheresisIf skin-directed therapy does not control the disease
Stem cell transplantAllogeneic haematopoietic stem cell transplantMay be offered to some patients with advanced disease (BAD); young, fit patients with Sézary syndrome that has not responded (Lymphoma Action)

What is cutaneous T-cell lymphoma?

Lymphoma is a cancer that starts in white blood cells called lymphocytes. Lymphoma Action explains there are two kinds, T cells and B cells, and that a skin lymphoma starts in the skin; a lymphoma that starts elsewhere and spreads to the skin is not a skin lymphoma. T-cell skin lymphoma, also called cutaneous T-cell lymphoma (CTCL), is the commonest group. BAD says that in CTCL the T-cells develop abnormalities that make them attack the skin.

Lymphoma Action says skin lymphoma is a rare and complex condition that can be hard to diagnose, that in most cases it does not affect life expectancy, and that it is treated more like a chronic condition.

Types of cutaneous T-cell lymphoma

Lymphoma Action describes many types, most of them very rare, and classes them as low-grade (slow-growing) or high-grade (fast-growing). It says most skin lymphomas are low-grade, and that sometimes a slow-growing type changes into a faster-growing type, which is rare.

Main types of T-cell skin lymphoma (Lymphoma Action)
TypeGradeKey points
Mycosis fungoidesLowMost common skin lymphoma, over half of all; develops over years or decades; about 3 in 4 diagnosed at an early stage
Folliculotropic mycosis fungoidesLowAbout 5% of mycosis fungoides; affects hair follicles, often head and neck, with hair loss, and is more likely to itch
Sézary syndromeHighRare; affects the blood as well as the skin, with red thickened skin all over, severe itching and swollen glands
Primary cutaneous anaplastic large cell lymphomaLowUsually one tumour on the skin; responds well to treatment with an excellent outlook
Lymphomatoid papulosisLowA CD30-positive disorder that responds well to treatment with an excellent outlook
Adult T-cell leukaemia/lymphoma and some rare typesHighNeed stronger treatment more urgently

How is cutaneous T-cell lymphoma diagnosed and staged?

BAD says skin biopsies, taken under local anaesthetic, are usually needed to confirm the diagnosis. Because the rash and biopsies may not show specific features, biopsies may have to be repeated several times over a period, and blood test results are usually normal. A firm diagnosis may take months or even years. Lymphoma Action says the time taken does not usually affect the prognosis.

Staging describes how far the lymphoma has spread. Lymphoma Action says tests may include a physical examination, blood tests, a blood test to measure circulating lymphoma cells, a CT or PET/CT scan, and sometimes a lymph node biopsy. Mycosis fungoides and Sézary syndrome share a four-stage system.

Stages of mycosis fungoides and Sézary syndrome (Lymphoma Action)
StageWhat it means
Stage 1Skin only (patches or plaques); 1A is less than a tenth of the skin, 1B a tenth or more
Stage 22A: patches or plaques with enlarged lymph nodes that do not contain lymphoma cells; 2B: one or more tumours in the skin
Stage 3Four-fifths or more of the skin affected with generalised redness (erythroderma); 3B means moderate numbers of lymphoma cells in the blood (Sézary syndrome)
Stage 4Spread to the bloodstream in large numbers, lymph nodes or other organs

What causes cutaneous T-cell lymphoma, and is it contagious?

BAD says the cause of mycosis fungoides is unknown, you cannot catch or pass it on, and it is not hereditary, although there have been very rare cases in which several family members developed it. Lymphoma Action says scientists do not know exactly what causes skin lymphoma, but some factors might increase risk.

These include age (two thirds of people are over 70), sex (men are around one and a half times more likely than women), possibly genetics, a virus called HTLV-1 for one subtype (adult T-cell leukaemia/lymphoma), and being a transplant recipient or having HIV. Most people with HTLV-1 do not develop lymphoma.

Outlook: how serious is cutaneous T-cell lymphoma?

Lymphoma Action says that in most cases skin lymphomas are long-term conditions that are not life-threatening, and treatment usually aims to control symptoms rather than cure. Most low-grade skin lymphomas never develop beyond early stages and problems come and go. With treatment, many people with advanced disease have long periods free of symptoms, although the lymphoma may come back more quickly than earlier-stage disease.

BAD says mycosis fungoides is a life-long condition that usually progresses slowly over many years, that it is difficult to predict how it will affect each person, and that many people live a normal life span. Some skin lymphomas are faster-growing and need stronger treatment urgently, which is why a specialist should confirm the exact type.

Follow-up depends on the type: Lymphoma Action says you might see your specialist every 6 to 12 months, or move to patient-initiated follow-up, if your lymphoma is slow-growing and stable, and as often as every 3 months if it is fast-growing.

When to see a doctor

See a GP if you have a rash that does not respond to treatment for eczema or psoriasis, patches that slowly spread or thicken over months, long-term widespread itching, or lumps in the skin. Ask for the skin to be reassessed or biopsied if a rash keeps returning, because BAD says early patches may look like common conditions and biopsies often need repeating.

Go to your GP promptly for unexplained weight loss, fevers, night sweats or swollen glands. If you have been diagnosed and develop a rapidly growing or bleeding skin lump, a spreading red painful rash, or a high temperature, contact your skin lymphoma team or NHS 111, as infection is more likely when skin is broken or the immune system is affected.

NHS and private pathways

On the NHS the route is usually GP to dermatology, then to a designated skin lymphoma clinic. BAD says difficult cases and those needing more than skin-directed therapy are discussed by a Supranetwork Skin Lymphoma Multidisciplinary Team, and there are several of these teams across the UK. Lymphoma Action says you might be referred to a specialist centre for treatment.

Private dermatologists can carry out biopsies and start skin-directed treatment, but advanced treatments and multidisciplinary discussion run through the specialist services. Ask for copies of your biopsy reports and make sure your GP and specialist team share the same information.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What is cutaneous T-cell lymphoma?

    A rare type of non-Hodgkin lymphoma that starts in the skin from T cells, a white blood cell. Lymphoma Action says fewer than 400 people are diagnosed each year in the UK, and it is usually treated like a chronic condition.

  • What are the first symptoms of cutaneous T-cell lymphoma?

    Dry, scaly or discoloured patches, often red and itchy, commonly on the buttocks or torso, developing slowly over years. They often look like eczema or psoriasis, according to Lymphoma Action and BAD.

  • Is cutaneous T-cell lymphoma the same as mycosis fungoides?

    Mycosis fungoides is the commonest type of CTCL. BAD says it is not a fungal infection despite the name. Sézary syndrome is another type, in which lymphoma cells also circulate in the blood.

  • Is cutaneous T-cell lymphoma curable?

    BAD says there is no known cure for mycosis fungoides, and treatment often clears the rash for a time but it usually comes back. Many people live a normal life span and can have long periods without symptoms.

  • How is cutaneous T-cell lymphoma treated?

    Moisturisers plus skin-directed therapy such as steroid creams, chlormethine gel, light therapy or radiotherapy for most people. Systemic treatments such as methotrexate, bexarotene, interferon or photopheresis are used if the skin treatments do not control it.

  • Is cutaneous T-cell lymphoma contagious?

    No. BAD says you cannot catch or pass on mycosis fungoides and it is not an infection. It is also not usually hereditary.

  • How long does diagnosis take?

    It can take weeks, months or even years. BAD says biopsies may need to be repeated several times, and Lymphoma Action says the length of time taken does not usually affect prognosis.

  • What is the life expectancy with cutaneous T-cell lymphoma?

    BAD says most people with mycosis fungoides have a normal life span, though advanced stages may have worse outcomes. Lymphoma Action says most skin lymphomas are not life-threatening. Your specialist can advise on your own type and stage.

  • What is Sézary syndrome?

    A rare, high-grade skin lymphoma affecting the blood as well as the skin, with red, thickened, itchy skin all over. Lymphoma Action says the first treatment choice is usually extracorporeal photopheresis, sometimes combined with other drugs.

  • Can CTCL be mistaken for eczema or psoriasis?

    Yes. Both BAD and Lymphoma Action say early patches can look like eczema, dermatitis or psoriasis, sometimes for many years. A rash that does not respond to usual treatment should be reviewed, and a biopsy may be needed.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-18, next review 2027-10-18.